AHA, Other Associations to Senate Finance Committee on Markup of Drug Pricing Bill

The AHA, AAMC and FAH agree with the Committee’s goal of reducing the price of drugs, and applaud many of the steps outlined in the description of the Chairman’s Mark of the Prescription Drug Pricing Reduction Act (PDPRA) of 2019. However, have serious concerns regarding the provisions that reduce reimbursements to providers and hospitals that administer drugs.